Previous 10 | Next 10 |
2024-01-30 16:03:51 ET Summary Harrow, Inc.'s stock price has fallen due to disappointing earnings releases in Q1, Q2, and Q3 of 2023. The company's various revenue buckets have not performed as well as expected, leading to a decline in revenue. Despite short-term challenges, ...
Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, today announced the appointments of Adrienne Graves, Ph.D., and Lauren Silvernail to the Company’s Board of Directors, effective immediately. Harrow’s Board now consists of six members. “I am deligh...
2024-01-19 13:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-01-11 10:34:40 ET More on Harrow Health Despite Q3 Earnings Miss, Harrow Is Still Appealing For 2024 Harrow, Inc. (HROW) Q3 2023 Earnings Call Transcript Implications Of Harrow's Short-Term Guidance Harrow stock tumbles 38% in wake of Q3 report, revised ...
VEVYE® Offers Rapid Onset with Clinically and Statistically Meaningful Improvement Beginning as Early as 15 Days 1 with Sustained Improvement over 56 Weeks 2 VEVYE® Patients to Have Access to a 100% Money-Back Guarantee Program 3 Harrow (Nasdaq: HRO...
Melt Pharmaceuticals, Inc. (“Melt”), a clinical‑stage pharmaceutical company developing novel approaches for procedural sedation, today provided a corporate update. The Company previously announced that MELT-300 achieved the primary sedation endpoint in its Phase 2 Pivota...
Agreements Support the Upcoming Launch of VEVYE ® Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, today announced that it has partnered with three leading healthcare technology platforms to expand U.S. availability of VEVYE ® (cyclosporine ophthal...
2024-01-02 07:09:05 ET Summary The Bloomberg report alleging an investigation into Franchise Group, Inc. (FRG)'s CEO relates to a fraud case against one of his associates from a previous employment, unlikely to impact RILY or FRG. Management is committed to its $1 quarterly distri...
2023-12-24 13:08:45 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips While the concept of short-squeeze stocks has been all the rage throughout most of the pandemic-disruption cycle, we may have been doing this all wrong. Rather, it’s time to address this...
2023-12-13 02:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
News, Short Squeeze, Breakout and More Instantly...
Harrow Health Inc. Company Name:
HROW Stock Symbol:
NASDAQ Market:
Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that management will participate in the following two investor conferences in May: B. Riley Securities 24 th Annual Institutional Investor Conference (Beverly Hilton Hotel, Beverly Hills, C...
Shares of Alibaba Group Holding Limited (NYSE:BABA) fell sharply during Tuesday's session following mixed first-quarter financial results. The...
Harrow Health, Inc. (NASDAQ: HROW) is one of today's top gainers. The company's shares have moved 33.64% on the day to $16.11. Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding busi...